JP2019507797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507797A5 JP2019507797A5 JP2018548079A JP2018548079A JP2019507797A5 JP 2019507797 A5 JP2019507797 A5 JP 2019507797A5 JP 2018548079 A JP2018548079 A JP 2018548079A JP 2018548079 A JP2018548079 A JP 2018548079A JP 2019507797 A5 JP2019507797 A5 JP 2019507797A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- synthetic nanocarrier
- administered
- uricase
- immunosuppressant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022011177A JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
| JP2024065367A JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307412P | 2016-03-11 | 2016-03-11 | |
| US62/307,412 | 2016-03-11 | ||
| US201662339944P | 2016-05-22 | 2016-05-22 | |
| US62/339,944 | 2016-05-22 | ||
| US201662346348P | 2016-06-06 | 2016-06-06 | |
| US62/346,348 | 2016-06-06 | ||
| US201662397832P | 2016-09-21 | 2016-09-21 | |
| US62/397,832 | 2016-09-21 | ||
| US201662398422P | 2016-09-22 | 2016-09-22 | |
| US62/398,422 | 2016-09-22 | ||
| US201662403664P | 2016-10-03 | 2016-10-03 | |
| US62/403,664 | 2016-10-03 | ||
| US201662430547P | 2016-12-06 | 2016-12-06 | |
| US62/430,547 | 2016-12-06 | ||
| US201762442948P | 2017-01-05 | 2017-01-05 | |
| US62/442,948 | 2017-01-05 | ||
| PCT/US2017/021991 WO2017156513A1 (en) | 2016-03-11 | 2017-03-11 | Formulations and doses of pegylated uricase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022011177A Division JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507797A JP2019507797A (ja) | 2019-03-22 |
| JP2019507797A5 true JP2019507797A5 (enExample) | 2020-04-16 |
| JP7417354B2 JP7417354B2 (ja) | 2024-01-18 |
Family
ID=58464628
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548079A Active JP7417354B2 (ja) | 2016-03-11 | 2017-03-11 | ペグ化ウリカーゼの処方物および用量 |
| JP2022011177A Active JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
| JP2024065367A Pending JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022011177A Active JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
| JP2024065367A Pending JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20170258927A1 (enExample) |
| EP (2) | EP3426285B1 (enExample) |
| JP (3) | JP7417354B2 (enExample) |
| KR (3) | KR102921105B1 (enExample) |
| CN (1) | CN109152819A (enExample) |
| AU (2) | AU2017230891B2 (enExample) |
| BR (1) | BR112018068249A2 (enExample) |
| CA (1) | CA3017365A1 (enExample) |
| DK (1) | DK3426285T3 (enExample) |
| ES (1) | ES2986077T3 (enExample) |
| FI (1) | FI3426285T3 (enExample) |
| HR (1) | HRP20241127T1 (enExample) |
| HU (1) | HUE068144T2 (enExample) |
| IL (2) | IL318183A (enExample) |
| LT (1) | LT3426285T (enExample) |
| MX (1) | MX2018011012A (enExample) |
| PL (1) | PL3426285T3 (enExample) |
| PT (1) | PT3426285T (enExample) |
| RS (1) | RS65941B1 (enExample) |
| SI (1) | SI3426285T1 (enExample) |
| WO (1) | WO2017156513A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8188224B2 (en) | 2005-04-11 | 2012-05-29 | Savient Pharmaceuticals, Inc. | Variant forms of urate oxidase and use thereof |
| EP4635567A3 (en) | 2009-06-25 | 2025-12-03 | Horizon Therapeutics USA, Inc. | Methods and kits for preventing infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy |
| EA201390660A1 (ru) | 2010-11-05 | 2013-11-29 | Селекта Байосайенсиз, Инк. | Модифицированные никотиновые соединения и связанные способы |
| US9987354B2 (en) | 2011-04-29 | 2018-06-05 | Selecta Biosciences, Inc. | Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells |
| US20130028857A1 (en) | 2011-07-29 | 2013-01-31 | Selecta Biosciences, Inc. | Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents |
| CN110251675A (zh) | 2013-05-03 | 2019-09-20 | 西莱克塔生物科技公司 | 降低或预防响应于非变应原性抗原的过敏反应的致耐受性合成纳米载体 |
| WO2016037161A2 (en) | 2014-09-07 | 2016-03-10 | Selecta Biosciences, Inc. | Methods and compositions for attenuating gene editing anti-viral transfer vector immune responses |
| IL318183A (en) * | 2016-03-11 | 2025-03-01 | Selecta Biosciences Inc | Formulations and doses of pegylated uricase |
| CN110234340A (zh) | 2016-11-11 | 2019-09-13 | 好利恩风湿病制药有限责任公司 | 泼尼松和尿酸酶分子的组合疗法及其用途 |
| US20200237881A1 (en) | 2019-01-30 | 2020-07-30 | Horizon Pharma Rheumatology Llc | Reducing immunogenicity to pegloticase |
| ES3036482T3 (en) | 2017-03-11 | 2025-09-19 | Cartesian Therapeutics Inc | Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant |
| WO2019010369A1 (en) | 2017-07-07 | 2019-01-10 | Allena Pharmaceuticals, Inc. | RECOMBINANT ENZYME URICASE |
| CN109875988B (zh) * | 2018-09-13 | 2021-08-27 | 江西中医药大学 | 一种化合物dhnb缩氨基脲的合成及其在防治痛风与高尿酸血症的应用 |
| US12121566B2 (en) | 2019-01-30 | 2024-10-22 | Horizon Therapeutics Usa, Inc. | Methods for treating gout |
| AU2020287627A1 (en) | 2019-06-04 | 2021-11-18 | Selecta Biosciences, Inc. | Formulations and doses of PEGylated uricase |
| KR102260478B1 (ko) * | 2019-08-19 | 2021-06-02 | 연세대학교 산학협력단 | 일나트륨 요소화물 결정 용해용 조성물 |
| EP4021482A4 (en) * | 2019-08-30 | 2023-04-19 | Horizon Therapeutics Ireland Dac | PEGLOTICASE FOR THE TREATMENT OF GOUT IN KIDNEY TRANSPLANT RECIPIENT |
| EP4048269A1 (en) * | 2019-10-21 | 2022-08-31 | Selecta Biosciences, Inc. | Methods and compositions for treating liver diseases and disorders |
| CN118384281A (zh) * | 2019-11-08 | 2024-07-26 | 西莱克塔生物科技公司 | 聚乙二醇化尿酸酶的制剂和剂量 |
| KR102200329B1 (ko) * | 2019-11-11 | 2021-01-08 | 광주과학기술원 | 반감기 증가를 위한 치료용 단백질-지방산 접합체 및 이의 용도 |
| CA3189100A1 (en) * | 2020-08-10 | 2022-02-17 | Paul PELOSO | Methods of treating gout |
| US12269875B2 (en) | 2023-08-03 | 2025-04-08 | Jeff R. Peterson | Gout flare prevention methods using IL-1BETA blockers |
| WO2025076412A1 (en) * | 2023-10-04 | 2025-04-10 | Gro Biosciences Inc. | Modified polypeptides and methods of making and uses thereof |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946929A (en) | 1983-03-22 | 1990-08-07 | Massachusetts Institute Of Technology | Bioerodible articles useful as implants and prostheses having predictable degradation rates |
| US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
| US4806621A (en) | 1986-01-21 | 1989-02-21 | Massachusetts Institute Of Technology | Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article |
| US5804178A (en) | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
| US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
| CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
| US5019379A (en) | 1987-07-31 | 1991-05-28 | Massachusetts Institute Of Technology | Unsaturated polyanhydrides |
| US5010167A (en) | 1989-03-31 | 1991-04-23 | Massachusetts Institute Of Technology | Poly(amide-and imide-co-anhydride) for biological application |
| US5399665A (en) | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
| US5512600A (en) | 1993-01-15 | 1996-04-30 | Massachusetts Institute Of Technology | Preparation of bonded fiber structures for cell implantation |
| US5514378A (en) | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| US5565215A (en) | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| US6007845A (en) | 1994-07-22 | 1999-12-28 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| US5716404A (en) | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
| US6123727A (en) | 1995-05-01 | 2000-09-26 | Massachusetts Institute Of Technology | Tissue engineered tendons and ligaments |
| JP3462313B2 (ja) | 1995-08-24 | 2003-11-05 | キッコーマン株式会社 | 変異型ウリカーゼ、変異型ウリカーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ウリカーゼの製造法 |
| US6095148A (en) | 1995-11-03 | 2000-08-01 | Children's Medical Center Corporation | Neuronal stimulation using electrically conducting polymers |
| US5902599A (en) | 1996-02-20 | 1999-05-11 | Massachusetts Institute Of Technology | Biodegradable polymer networks for use in orthopedic and dental applications |
| US6258823B1 (en) | 1996-07-12 | 2001-07-10 | Ariad Pharmaceuticals, Inc. | Materials and method for treating or preventing pathogenic fungal infection |
| US5837752A (en) | 1997-07-17 | 1998-11-17 | Massachusetts Institute Of Technology | Semi-interpenetrating polymer networks |
| US6632922B1 (en) | 1998-03-19 | 2003-10-14 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6686446B2 (en) | 1998-03-19 | 2004-02-03 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6506577B1 (en) | 1998-03-19 | 2003-01-14 | The Regents Of The University Of California | Synthesis and crosslinking of catechol containing copolypeptides |
| CN1406140A (zh) | 2000-02-28 | 2003-03-26 | 吉倪塞思公司 | 纳米胶囊包封系统与方法 |
| GB0025414D0 (en) | 2000-10-16 | 2000-11-29 | Consejo Superior Investigacion | Nanoparticles |
| US6913915B2 (en) | 2001-08-02 | 2005-07-05 | Phoenix Pharmacologics, Inc. | PEG-modified uricase |
| US6818732B2 (en) | 2001-08-30 | 2004-11-16 | The Regents Of The University Of California | Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers |
| EP3242318A1 (en) | 2003-12-19 | 2017-11-08 | The University of North Carolina at Chapel Hill | Monodisperse micro-structure or nano-structure product |
| EP1768692B8 (en) | 2004-07-01 | 2015-06-17 | Yale University | Targeted and high density drug loaded polymeric materials |
| EP3424525A1 (en) | 2007-10-12 | 2019-01-09 | Massachusetts Institute Of Technology | Vaccine nanotechnology |
| CN101676291B (zh) | 2008-09-18 | 2012-05-09 | 上海海和药物研究开发有限公司 | 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途 |
| US9987354B2 (en) * | 2011-04-29 | 2018-06-05 | Selecta Biosciences, Inc. | Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells |
| CN110251675A (zh) * | 2013-05-03 | 2019-09-20 | 西莱克塔生物科技公司 | 降低或预防响应于非变应原性抗原的过敏反应的致耐受性合成纳米载体 |
| WO2014179771A1 (en) * | 2013-05-03 | 2014-11-06 | Selecta Biosciences, Inc. | Dosing combinations for reducing undesired humoral immune responses |
| KR102656139B1 (ko) | 2014-11-05 | 2024-04-11 | 셀렉타 바이오사이언시즈, 인크. | 라팔로그를 포함하는 합성 나노담체 제조에서의 저hlb 계면활성제의 사용과 관련된 방법 및 조성물 |
| IL318183A (en) * | 2016-03-11 | 2025-03-01 | Selecta Biosciences Inc | Formulations and doses of pegylated uricase |
-
2017
- 2017-03-11 IL IL318183A patent/IL318183A/en unknown
- 2017-03-11 CA CA3017365A patent/CA3017365A1/en active Pending
- 2017-03-11 PL PL17715298.0T patent/PL3426285T3/pl unknown
- 2017-03-11 DK DK17715298.0T patent/DK3426285T3/da active
- 2017-03-11 MX MX2018011012A patent/MX2018011012A/es unknown
- 2017-03-11 HR HRP20241127TT patent/HRP20241127T1/hr unknown
- 2017-03-11 SI SI201731543T patent/SI3426285T1/sl unknown
- 2017-03-11 BR BR112018068249-7A patent/BR112018068249A2/pt unknown
- 2017-03-11 KR KR1020227029367A patent/KR102921105B1/ko active Active
- 2017-03-11 ES ES17715298T patent/ES2986077T3/es active Active
- 2017-03-11 HU HUE17715298A patent/HUE068144T2/hu unknown
- 2017-03-11 EP EP17715298.0A patent/EP3426285B1/en active Active
- 2017-03-11 RS RS20240946A patent/RS65941B1/sr unknown
- 2017-03-11 JP JP2018548079A patent/JP7417354B2/ja active Active
- 2017-03-11 US US15/456,520 patent/US20170258927A1/en not_active Abandoned
- 2017-03-11 LT LTEPPCT/US2017/021991T patent/LT3426285T/lt unknown
- 2017-03-11 CN CN201780028609.1A patent/CN109152819A/zh active Pending
- 2017-03-11 KR KR1020187029146A patent/KR20180120753A/ko not_active Ceased
- 2017-03-11 WO PCT/US2017/021991 patent/WO2017156513A1/en not_active Ceased
- 2017-03-11 EP EP24177803.4A patent/EP4445955A3/en active Pending
- 2017-03-11 KR KR1020267002811A patent/KR20260023090A/ko active Pending
- 2017-03-11 AU AU2017230891A patent/AU2017230891B2/en active Active
- 2017-03-11 FI FIEP17715298.0T patent/FI3426285T3/fi active
- 2017-03-11 PT PT177152980T patent/PT3426285T/pt unknown
-
2018
- 2018-09-12 IL IL261700A patent/IL261700A/en unknown
-
2022
- 2022-01-27 JP JP2022011177A patent/JP7547402B2/ja active Active
-
2024
- 2024-04-15 JP JP2024065367A patent/JP2024102099A/ja active Pending
- 2024-07-15 AU AU2024204851A patent/AU2024204851A1/en not_active Abandoned
- 2024-08-29 US US18/818,714 patent/US20250090451A1/en active Pending
- 2024-10-31 US US18/933,195 patent/US20250057756A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019507797A5 (enExample) | ||
| JP2024102099A5 (enExample) | ||
| JP2022068180A5 (enExample) | ||
| FI3426285T3 (fi) | Pegyloidun urikaasin formulaatioita ja annoksia | |
| JP2020510687A5 (enExample) | ||
| US20230414521A1 (en) | Sustained-release formulations of colchicine and methods of using same | |
| CN102869349A (zh) | 耐酒精的肠溶药物组合物 | |
| JP2018520189A5 (enExample) | ||
| KR20210147083A (ko) | 다발경화증 치료용 조합 요법 | |
| CN102781240A (zh) | 用拉喹莫德和甲氨蝶呤的组合治疗类风湿性关节炎 | |
| JP2009215293A5 (enExample) | ||
| US20190307707A1 (en) | Methods of administering amantadine | |
| JP2019501881A5 (enExample) | ||
| CN115190795A (zh) | 聚乙二醇化尿酸酶的制剂和剂量 | |
| BR112020008128A2 (pt) | comprimidos de liberação retardada de deferiprona e métodos para utilização dos mesmos | |
| EP3079704B1 (en) | A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation | |
| JP2015518002A5 (enExample) | ||
| US20180368458A1 (en) | Time release vitamins and minerals in edible oils | |
| JPWO2020247625A5 (enExample) | ||
| Cristancho et al. | The role of quetiapine extended release in the treatment of bipolar depression | |
| JP2016504390A5 (enExample) | ||
| JP6697539B2 (ja) | コルヒチンの徐放性製剤およびその使用方法 | |
| JPWO2021092354A5 (enExample) | ||
| RU2021136782A (ru) | Композиции и дозы пегилированной уриказы | |
| Sullivan | Phase II findings in AD drug trial ‘Not All Bad’ |